CHFHY yields 3.84% · JNJ yields 2.13%● Live data
📍 CHFHY pulled ahead of the other in Year 1
Combined, CHFHY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CHFHY + JNJ for your $10,000?
China Foods Limited, an investment holding company, manufactures, distributes, markets, and sells Coca-Cola series products in the People's Republic of China. The company offers sparkling drinks, juices, water, milk drinks, energy drinks, tea, coffee, functional nutrition drinks, sports and plant-based protein drinks, and alcoholic drinks. It is also involved in the production, sale, and distribution of beverage bottles; wholesale and retail of pre-packaged foods, and raw and auxiliary materials; provision of supply chain information consultation, management, and other services; and wholesale of packaged foods. In addition, the company provides enterprise management and consulting, business information consulting, and marketing planning services, as well as computer information system development, consulting, promotion, and other services. Further, it engages in the food business and internet sale of food. The company was formerly known as COFCO International Limited. China Foods Limited was founded in 1990 and is headquartered in Causeway Bay, Hong Kong. China Foods Limited is a subsidiary of China Foods (Holdings) Limited.
Full CHFHY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.